Point of view: use of left ventricular function as prognostic factor.

This publication has 16 references indexed in Scilit:

• An endothelin family
  Coronary Artery Disease, 1991
• In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin
  The Lancet, 1990
• Endothelin-3 concentrations in human plasma: The increased concentrations in patients undergoing haemodialysis
  Biochemical and Biophysical Research Communications, 1990
• Does vessel patency at the time of hospital discharge following thrombolytic therapy predict survival?
  Journal of the American College of Cardiology, 1990
• Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide.
  Journal of Clinical Investigation, 1990
• Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of the Netherlands
  Journal of the American College of Cardiology, 1989
• INCREASED PLASMA CONCENTRATIONS OF ENDOTHELIN-1 AND BIG ENDOTHELIN-1 IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1989
• Effect of Intravenous Streptokinase as Compared with That of Tissue Plasminogen Activator on Left Ventricular Function after First Myocardial Infarction
  New England Journal of Medicine, 1989
• Electrophysiologic effects of thrombolytic therapy in patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formation
  Journal of the American College of Cardiology, 1988
• Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial Infarction
  New England Journal of Medicine, 1987